Ligand Pharmaceuticals | LGND - EPS - Lucro por Ação


Fiscal Calendário Atual Consenso Anterior Data
FY2026Q3 Sep/2025 2.54 3.09 Nov/05
FY2026Q2 Jun/2026 2.37 1.95 1.60 Aug/06
FY2026Q1 Mar/2026 1.63 1.82 1.33 May/07
FY2025Q4 Dec/2025 2.02 1.49 1.27 Feb/26
FY2025Q3 Sep/2025 3.09 1.93 1.84 Nov/06




Eps Alterar Data
Agenus USD 1.02 1.32 2026-03
Amgen USD 6.29 1.14 2026-06
Anika Therapeutics USD 0.13 0.35 2025-12
Arrowhead Research USD -1.36 0.43 2026-06
Baxter International USD 0.56 0.2 2026-06
Bristol-Myers Squibb USD 2.04 0.46 2026-06
Eli Lilly USD 8.38 0.17 2026-06
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Enviri Corporation USD -1.02 0.92 2025-12
Gilead Sciences USD -6.75 8.78 2026-06
GlaxoSmithKline GBP 0.51 0.08 2026-06
Glaxosmithkline GBP 0.62 0.41 2026-03
Heron Therapeutics USD -0.02 0.02 2025-12
Insmed USD -0.06 0.7 2026-06
Intrexon USD -0.1 0.03 2024-06
Ionis Pharmaceuticals USD -0.69 0.13 2026-06
Karyopharm Therapeutics USD -1.02 1.2 2026-03
Ligand Pharmaceuticals USD 2.37 0.74 2026-06
MacroGenics USD -0.58 0.36 2026-03
Merck USD -0.13 1.15 2026-06
Pacira USD 0.73 0.13 2026-06
Pfizer USD 0.77 0.02 2026-06
Rigel Pharmaceuticals USD 0.7 0.76 2024-09
Sangamo BioSciences USD -0.18 0.1 2024-06
Veracyte USD 0.54 0.02 2026-06